SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 136 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $12,242,000 | -44.0% | 641,932 | -42.7% | 0.14% | -39.6% |
| Q1 2016 | $21,860,000 | -51.4% | 1,119,893 | -3.8% | 0.24% | -47.8% |
| Q4 2015 | $44,934,000 | -34.4% | 1,164,690 | -45.4% | 0.45% | -17.6% |
| Q3 2015 | $68,513,000 | -36.3% | 2,133,684 | -39.6% | 0.55% | -21.0% |
| Q2 2015 | $107,499,000 | +147.4% | 3,532,677 | +8.0% | 0.69% | +192.8% |
| Q1 2015 | $43,457,000 | -8.2% | 3,272,400 | 0.0% | 0.24% | +0.4% |
| Q4 2014 | $47,352,000 | -30.7% | 3,272,400 | +1.1% | 0.24% | -25.2% |
| Q3 2014 | $68,301,000 | -12.9% | 3,237,000 | +22.9% | 0.31% | -0.3% |
| Q2 2014 | $78,437,000 | +24.0% | 2,633,000 | 0.0% | 0.32% | +26.5% |
| Q1 2014 | $63,271,000 | +17.9% | 2,633,000 | -0.1% | 0.25% | +21.5% |
| Q4 2013 | $53,675,000 | -20.6% | 2,635,000 | +84.1% | 0.20% | -24.6% |
| Q3 2013 | $67,586,000 | -0.6% | 1,431,000 | -19.9% | 0.27% | -8.4% |
| Q2 2013 | $67,995,000 | – | 1,787,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |